Sentinel lymph node biopsies in melanoma: how many nodes do we really need?

Area of Science:

• Oncology
• Surgical Pathology
• Nuclear Medicine

Background:

• Sentinel lymph node (SLN) biopsy is crucial for staging cutaneous melanoma.
• Accurate detection of lymphatic spread is vital for patient management.
• Determining the optimal number of SLNs for biopsy remains an area of investigation.

Purpose of the Study:

• To identify the adequate number of sentinel lymph nodes (SLNs) for reliable detection of malignant spread in cutaneous melanoma patients.
• To correlate radiotracer uptake with the risk of harboring malignancy in SLNs.
• To optimize the surgical strategy for SLN biopsy in melanoma.

Main Methods:

• Prospective collection of radiotracer counts and histopathology reports for SLN biopsies (1998-2005).
• Ranking lymph nodes by radiotracer counts ('hottest nodes').
• Analysis of the relationship between radioactivity and malignancy risk.

Main Results:

• Nodal metastases were found in 10.5% of patient basins.
• Excising the 3 hottest nodes plus all blue nodes achieved 100% detection of lymphatic malignancy.
• 98% of positive lymph nodes showed radiotracer counts >30% of the hottest node.

Conclusions:

• Removing only the hottest SLN is insufficient for detecting melanoma metastasis.
• The combination of the 3 hottest nodes and all blue nodes is adequate for detecting regional lymphatic spread.
• Biopsying nodes with <30% radiotracer uptake may be unnecessary.